Regulation of Antibody Production Mediated by Fcγ Receptors, IgG Binding Factors, and IgG Fc-Binding Autoantibodies

References

• Möller G. Antibody mediated suppression of the immune response is determinant specific. Eur. J. Immunol. 1985; 15: 409
   PubMed Web of Science ®Google Scholar
• Zalcberg I., Silveira A. V., Möller G. Regulation of the antibody response to sheep erythrocytes by monoclonal IgG antibodies. Eur. J. Immunol. 1987; 17: 1343
   PubMed Web of Science ®Google Scholar
• Uhr J. W., Möller G. Regulatory effect of antibody on the immune response. Adv. Immunol. 1968; 8: 81
   PubMedGoogle Scholar
• Voisin G. A. Role of antibody classes in the regulatory facilitation reaction. Immunol. Rev. 1980; 49: 3
   PubMed Web of Science ®Google Scholar
• Morgan E. L., Weigle W. O. Biological activities residing in the Fc region of immunoglobulin. Adv. Immunol. 1987; 40: 61
   PubMed Web of Science ®Google Scholar
• Jerne N. K. Idiotypic networks and other preconceived ideas. Immunol. Rev. 1984; 79: 5
   PubMed Web of Science ®Google Scholar
• Fridman W. H., Daeron M., Amigorena S., Rabourdin-Combe C., Neauport-Sautes C. Bases for an isotypic network. Mol. Immunol. 1986; 23: 1141
   PubMed Web of Science ®Google Scholar
• Brüggemann M., Rajewsky K. Regulation of the antibody response against hapten-coupled erythrocytes by monoclonal anti-hapten antibodies of various isotypes. Cell. Immunol. 1982; 71: 165
   Web of Science ®Google Scholar
• Heyman B., Wigzell H. Immunoregulation by monoclonal sheep erythrocyte specific IgG-antibodies: suppression is correlated to level of antigen binding and not to isotype. J. Immunol. 1984; 132: 1136
   PubMed Web of Science ®Google Scholar
• St. Sinclair N. K. C. Regulation of the immune response. I. Reduction in ability to inhibit longlasting IgG immunological priming after removal of the Fc fragment. J. Exp. Med. 1969; 129: 1183
   PubMed Web of Science ®Google Scholar
• Heyman B., Nose M., Weigle W. O. Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression. J. Immunol. 1985; 134: 4018
   PubMed Web of Science ®Google Scholar
• Feinstein A., Rowe A. J. Molecular mechanism of formation of an antigen-antibody complex. Nature 1965; 205: 147
   PubMed Web of Science ®Google Scholar
• Valentine R. C., Green M. M. Electron microscopy of and antibody-hapten complex. J. Mol. Biol 1997; 27: 615
   Google Scholar
• Metzger H. Effect of antigen binding on the properties of antibody. Adv. Immunol. 1974; 18: 169
   PubMedGoogle Scholar
• Huber R., Deisenhofer J., Colman P. M., Matsushima M., Palm W. Crystallographic structure studies of an IgG molecule and an Fc fragment. Nature 1976; 264: 415
   PubMed Web of Science ®Google Scholar
• Huber R., Deisenhofer J., Colman P. M., Matsushima M., Palm W. X-ray diffraction analysis of immunoglobulin structure. Das Immunsystem, F. Melchers, K. Rajewsky. Springer-Verlag, Berlin 1976
   Google Scholar
• Schlessinger J., Steiberg I. Z., Givol D., Hochman J., Pecht I. Antigen-induced conformational changes in antibodies and in their Fab fragments studied by circular polarisation of fluorescence. Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 2775
   PubMed Web of Science ®Google Scholar
• Pecht I. Recognition and allostery in the mechanism of antibody action. Das Immunsystem, F. Melchers, K. Rajewsky. Springer-Verlag, Berlin 1976; 41
   Google Scholar
• Zavodszky P., Jaton J. C., Venyaminov Yu. S., Medgyesi G. A. Increase of conformational stability of two homogenous rabbit immunoglobulin G after hapten binding. Mol. Immunol. 1981; 18: 39
   PubMed Web of Science ®Google Scholar
• Willan K. J., Golding B., Givol D., Dweck R. A. Specific spin labeling of the Fc region of immunoglobulins. FEBS Lett. 1977; 80: 133
   PubMed Web of Science ®Google Scholar
• Jaton J. C., Wright J. K., Schmidt-Kessen A., Engel J. Interactions of monovalent and multivalent oligosaccharide tigands with homogenous anti-polysaccharide antibody and its possible effects on the conformation of the IgG molecule. Immunology 1978, J. Gergely, G. A. Medgyesi, S. R. Hollan. Akademiai Kiado, Budapest 1978; 277
   Google Scholar
• Metzger H. The effect of antigen on antibodies: recent studies. Contemp. Top. Mol. Immunol. 1978; 1: 119
   Google Scholar
• Jaton J. C., Huser H., Braun D. G., Givol D., Pecht I., Schlessinger J. Conformational changes induced in homogenous anti-Type III pneumococcal antibody by oligosaccharides in increasing size. Biochemistry 1975; 14: 5312
   Web of Science ®Google Scholar
• Jaton J. C., Huser H., Reisen W. F., Schlessinger J., Givol D. The binding of complement by complexes formed between a rabbit antibody and oligosaccharides of increasing size. J. Immunol. 1976; 116: 1363
   PubMed Web of Science ®Google Scholar
• Gergely J., Medgyesi G. A., Füst G., Rajnavölgyi E. Constitution of immune complexes and their interaction with the complement system. Immunology 1978, J. Gergely, G. A. Medgyesi, R. S. Hollan. Akademiai Kiado, Budapest 1978; 293
   Google Scholar
• Medgyesi G. A., Füst G., Gergely J., Jaton J. C. Activation of the classical complement pathway by homogenous anti-SIII antibody bound to bivalent or trivalent oligosaccharide antigens. Mol. Immunol. 1979; 16: 949
   PubMed Web of Science ®Google Scholar
• Pecht I., Ehrenberg B., Calef E., Arnon R. Conformational changes and complement activation induced upon antigen binding to antibodies. Biochem. Biophys. Res. Comm. 1977; 74: 1302
   PubMed Web of Science ®Google Scholar
• Metzger H. General aspects of antibody structure and function. Fc Receptors and the Action of Antibodies, H. Metzger. Telford Press, Caldwell, NJ 1990; 7
   Google Scholar
• Metzger H. Antibodies as effector molecules. Harvey Lect. Ser. 1986; 80: 40
   Google Scholar
• Sheriff S., Silverton E. W., Padlan E. A., Cohen G. H., Smith-Gill S. J., Finzel B. C., Davis D. R. Three-dimensional structure of an antibody-antigen complex. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 8075
   PubMed Web of Science ®Google Scholar
• Fischmann T., Souchon H., Riottot M. M., Tello D., Poljak R. J. Crystallization and preliminary X-ray diffraction studies of two new antigen-antibody (lysozyme-Fab) complexes. J. Mol. Biol. 1988; 203: 527
   PubMed Web of Science ®Google Scholar
• Wrigley N. G., Brown E. B., Skehel J. J. Electron microscopic evidence for the axial rotation and inter-domain flexibility of the Fab regions of IgG. J. Mol. Biol. 1983; 169: 771
   PubMed Web of Science ®Google Scholar
• Wade R. H., Taveau J. C., Lamy J. N. Concerning the axial rotation flexibility of the Fab regions of immunoglobulin G. J. Mol. Biol. 1989; 206: 349
   PubMed Web of Science ®Google Scholar
• Burton R. D. Antibody: the flexible adaptor molecule. TIBS 1990; 15: 64
   PubMed Web of Science ®Google Scholar
• Klein M., Haeffner-Cavaillon N., Isenman D. E., Rivat C., Navia M. A., Davies D. R., Dorrington K. J. Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region. Proc. Natl. Acad. Sci. U.S.A. 1981; 78: 524
   PubMed Web of Science ®Google Scholar
• Dorrington K. J., Klein M. Aspects of immunoglobulin G structure relevant to its interaction with Fc receptors. Mol. Immunol. 1982; 19: 1215
   PubMedGoogle Scholar
• Burton D. R. The conformation of antibodies. Fc Receptors and the Action of Antibodies, H. Metzger. Telford Press, Caldwell, NJ 1990; 31
   Google Scholar
• Oi V. T., Vuong T. M., Hardy R., Reidler J., Dangl J., Herzenberg L. A., Stryer L. Correlation between segmental flexibility and effector function of antibodies. Nature (London) 1984; 307: 136
   PubMed Web of Science ®Google Scholar
• Dangl J. L., Wensel T. G., Morrison S. L., Stryer L., Herzenberg L. A., Oi V. T. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J. 1988; 7: 1989
   PubMed Web of Science ®Google Scholar
• Rabat E. A., Wu T. T., Bilofsky H., Reid-Miller M., Perry H. Sequences of proteins of immunological interest. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. 1983
   Google Scholar
• Marquart M., Deisenhofer J., Huber R., Palm W. Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 and 1.9 Å resolution. J. Molec. Biol 1980; 141: 369
   PubMed Web of Science ®Google Scholar
• Burton D. R. Immunoglobulin G: functional sites. Mol. Immunol 1985; 22: 161
   PubMed Web of Science ®Google Scholar
• Birshtein B. K., Campbell R., Diamond B. Effects of immunoglobulin structure on Fc receptor binding: a mouse myeloma variant immunoglobulin with a γ2b-γ2a hybrid heavy chain having a complete γ2a Fc region fails to bind to γ2a Fc receptors on mouse macrophages. J. Immunol. 1982; 129: 610
   PubMed Web of Science ®Google Scholar
• Rademacher T. W., Dwelt R. A. Structural, functional and conformation analysis of immunoglobulin G-derived asparagine-linked oligosaccharides. Prog. Immun. 1984; 5: 95
   Google Scholar
• Mizouchi T., Taniguchi T., Shimizu A., Kobata A. Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. J. Immunol 1982; 129: 2016
   PubMed Web of Science ®Google Scholar
• Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B protein A from Staphylococcus aureus at 2.9 and 2.8 Å resolution. Biochemistry 1981; 20: 2361
   PubMed Web of Science ®Google Scholar
• Sutton B. J., Phillips D. C. The three-dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G. Biochem. Soc. Trans. 1983; 11: 130
   Web of Science ®Google Scholar
• Leatherbarrow R. J., Rademacher T. W., Dwek R. A., Woof J. M., Clark A., Burton D. R., Richardson N., Feinstein A. Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component CI and interaction with human monocyte Fc receptor. Molec. Immunol 1985; 22: 407
   PubMed Web of Science ®Google Scholar
• Padlan E. A. X-ray diffraction studies of antibody constant regions. Fc Receptors and the Action of Antibodies, H. Metzger. Telford Press, Caldwell, NJ 1990; 12
   Google Scholar
• Poljak R. J., Amzel L. M., Avey H. P., Chen B. L., Phizackerley R. P., Saul F. Three-dimensional structure of the Fab' fragment of a human immunoglobulin at 2.8 Å resolution. Proc. Natl. Acad. Sci. U.S.A. 1973; 70: 3305
   PubMed Web of Science ®Google Scholar
• Davies D. R., Metzger H. Structural basis of antibody function. Annu. Rev. Immunol. 1983; 1: 87
   PubMed Web of Science ®Google Scholar
• Williams A. F., Barclay A. N. The immunoglobulin superfamily — domains for cell surface recognition. Annu. Rev. Immunol 1988; 6: 381
   PubMed Web of Science ®Google Scholar
• Reid K. B. M. Proteins involved in the activation and control of the two path ways of human complement. Biochem. Soc. Trans. 1983; 11: 1
   PubMed Web of Science ®Google Scholar
• Schumaker V. N., Calcott M. A., Spiegelberg H. L., Müller-Eberhard H. J. Ultracentrifuge studies of the binding of IgG of different subclasses to the C1q subunit of the first component of complement. Biochemistry 1976; 16: 5175
   Google Scholar
• Painter R. H., Foster D. B., Gardner B., Hughes-Jones N. C. Functional affinity constants of subfragments of immunoglobulin G for C1q. Molec. Immunol 1982; 19: 127
   PubMed Web of Science ®Google Scholar
• Burton D. R., Boyd J., Brampton A. D., Easterbrook-Smith S. B., Emanuel E. J., Novotny J., Rademacher T. W., van Schravendijk M. R., Sternberg M. J. E., Dwek R. A. The C1q receptor site on immunoglobulin G. Nature (London) 1980; 288: 338
   PubMed Web of Science ®Google Scholar
• Wright K. J., Tschopp J., Jaton J.-C., Engel J. Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement. Biochem. J. 1980; 187: 775
   PubMed Web of Science ®Google Scholar
• Dower S. K., Segal D. M. C1q binding to antibody-coated cells: predictions from a simple multivalent model. Mol. Immunol 1981; 18: 823
   PubMed Web of Science ®Google Scholar
• Liberti P. A., Bausch D. M., Schoenberg L. M. On the mechanism of C1q binding to antibody. I. Aggregation and/or distortion of IgG vs. combining site transmitted effects. Mol. Immunol 1982; 19: 143
   PubMed Web of Science ®Google Scholar
• Colomb M., Porter R. R. Characterization of a plasmin-digest fragment of rabbit immunoglobulin gamma that binds antigen and complement. Biochem. J. 1975; 145: 177
   PubMed Web of Science ®Google Scholar
• Yasmen D., Ellerson J. R., Dorrington K. J., Painter R. H. The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cγ2 and C-γ3 homology regions of human immunoglobulin G. J. Immunol 1976; 116: 518
   PubMed Web of Science ®Google Scholar
• Boackle R. J., Johnson B. J., Caughman G. B. An IgG primary sequence exposure theory for complement activation using synthetic peptides. Nature (London) 1979; 282: 742
   PubMed Web of Science ®Google Scholar
• Pristowsky M. B., Kehoe J. M., Erickson B. W. Inhibition of the classical complement pathway by synthetic peptides from the second constant domain of the heavy chain of IgG. Biochemistry 1981; 20: 6349
   PubMed Web of Science ®Google Scholar
• Brunhouse R., Cebra J. J. Isotypes of IgG: comparison of the primary structures of isotypes which differ in their ability to activate complement. Molec. Immunol 1979; 16: 907
   PubMed Web of Science ®Google Scholar
• Lukas T. J., Munoz H., Erickson B. W. Inhibition of C1-mediated immune hemolysis by monomelic and dimeric peptides from the second constant domain of human immunoglobulin G. J. Immunol 1981; 127: 2555
   PubMed Web of Science ®Google Scholar
• Duncan A. R., Winter G. The binding site for C1q on IgG. Nature (London) 1988; 332: 563
   PubMed Web of Science ®Google Scholar
• Winkelhake J. L., Kunicki T. J., Elcomebe B. M., Asrerm R. H. Effects of pH treatments and deglycosylation of rabbit immunoglobulin G on the binding of C1q. J. Biol. Chem. 1980; 255: 2822
   PubMed Web of Science ®Google Scholar
• Nose M., Wlgzell H. Biological significance of carbohydrate chains on monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 6632
   PubMed Web of Science ®Google Scholar
• Berken A., Benacerraf B. Properties of antibodies cytophilic for macrophages. J. Exp. Med. 1966; 146: 241
   Google Scholar
• Lynch R. G., Sandor M., Waldschmidt T. J., Mathur A., Schaiff W. T., Berg D. J., Snapp K., Mueller A., Robinson M. G., Noben N., Rosenberg M. G. Lymphocyte Fc receptors: expression, regulation and function. Mol. Immunol. 1990; 27: 1167
   PubMed Web of Science ®Google Scholar
• Anderson C. L., Looney R. J. Human leukocyte IgG Fc receptors. Immunol. Today 1986; 7: 264
   PubMedGoogle Scholar
• Anderson C. L. Isolation of the receptor for human IgG from a human monocyte cell line (U937) and from human peripheral blood monocytes. J. Exp. Med 1982; 156: 1794
   PubMed Web of Science ®Google Scholar
• Perussia B., Dayton E. T., Lazarus R., Fanning V., Trinchieri G. Immune interferon induces the receptor for IgG1 on human monocytic and myeloid cells. J. Exp. Med. 1983; 158: 1092
   PubMed Web of Science ®Google Scholar
• Frey J., Engelhardt W. Characterization and structural analysis of Fc receptors of human monocytes, a monoblast cell line (U937) and a myeloblast cell line (HL-60) by monoclonal antibody. Eur. J. Immunol. 1987; 17: 583
   PubMed Web of Science ®Google Scholar
• Allen J. M., Seed B. Nucleotide sequence of three cDNAs for the human high affinity Fc receptor (FcRI). Nucleic Acid Res. 1988; 16: 11824
   PubMed Web of Science ®Google Scholar
• Allen J. M., Seed B. Isolation and expression of functional high-affinity Fc receptor complementary DNAs. Science 1989; 243: 378
   PubMed Web of Science ®Google Scholar
• Rosenfeld S. I., Looney R. J., Leddy J. P., Abraham D. C., Anderson C. L. Human platelet Fc receptor for immunoglobulin G. Identification as a 40,000-molecular-weight membrane protein shared by monocytes. J. Clin. Invest. 1985; 76: 2317
   PubMed Web of Science ®Google Scholar
• Looney R. J., Abraham G. N., Anderson C. L. Human monocytes and U937 cells bear two distinct Fc receptors for IgG. J. Immunol. 1986; 136: 1641
   PubMed Web of Science ®Google Scholar
• Tax W. J. M., Willems H. W., Reekers P. P. M., Capel P. J. A., Koene R. A. P. Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature 1983; 304: 445
   PubMed Web of Science ®Google Scholar
• Lewis V. A., Koch T., Plutner H., Mellman I. A complementary cDNA clone for a macrophage-lymphocyte Fc receptor. Nature 1986; 324: 372
   PubMed Web of Science ®Google Scholar
• Seki T. Identification of multiple isoforms of the low-affinity human IgG Fc receptor. Immunogenetics 1989; 30: 5
   PubMed Web of Science ®Google Scholar
• Brooks D. G., Qiu W. Q., Luster A. D., Ravetch J. V. Structure and expression of human IgG FcRII (CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J. Exp. Med. 1989; 170: 1369
   PubMed Web of Science ®Google Scholar
• Stuart S. G., Trounstine M. L., Vaux D. J. T., Koch T., Martens C. L., Mellman I., Moore K. W. Isolation and expression of cDNA clones encoding a human receptor for IgG (Fc-γRII). J. Exp. Med. 1987; 166: 1668
   PubMed Web of Science ®Google Scholar
• Stengelin S., Stamenkovic I., Seed B. Isolation of cDNAs for two distinct human Fc receptors by ligand affinity cloning. EMBO J. 1988; 7: 1053
   PubMed Web of Science ®Google Scholar
• Engelhardt W., Geerds C., Frey J. Distribution, inducibility and biological function of the cloned and expressed human βFc receptor II. Eur. J. Immunol. 1990; 20: 1367
   PubMed Web of Science ®Google Scholar
• Ravetch J. V., Anderson C. L. Fc-γR family: proteins, transcripts, and genes. Fc Receptors and the Action of Antibodies, H. Metzger. Telford Press, Caldwell, NJ 1990; 211
   Google Scholar
• Perussia B., Acuto O., Terhorst C., Faust J., Lazarus R., Fanning V., Trinchieri G. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor function. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane. J. Immunol. 1983; 130: 2142
   PubMed Web of Science ®Google Scholar
• Clarkson S. B., Ory P. A. CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes. J. Exp. Med. 1988; 167: 408
   PubMed Web of Science ®Google Scholar
• Lanier L. L., Ruitenberg J. J., Phillips J. H. Functional and biochemical analysis of CD 16 antigen on natural killer cells and granulocytes. J. Immunol. 1988; 141: 3478
   PubMed Web of Science ®Google Scholar
• Karas S. P., Rosse W. F., Kurlander R. J. Characterization of the IgG-Fc receptor on human platelets. Blood 1982; 60: 1277
   PubMed Web of Science ®Google Scholar
• Fleit H. B., Wright S. D., Unkeless J. C. Human neutrophil Fc receptor distribution and structure. Proc. Natl. Acad. Sci. U.S.A. 1982; 79: 3275
   PubMed Web of Science ®Google Scholar
• Huizinga T. W. J., van der Schoot C. E., Jost C., Klaassen R., Kleljer M., von dem Borne Kr E. G., Roos D., Tetteroo P. A. T. The PI-linked receptor FcRIII is released on stimulation of neutrophils. Nature 1988; 333: 667
   PubMed Web of Science ®Google Scholar
• Selvaraj P., Rossed W. F., Silber R., Springer T. A. The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal hemoglobinuria. Nature 1988; 333: 565
   PubMed Web of Science ®Google Scholar
• Ravetch J. V., Perussia B. Alternative membrane forms of FcγRIII(CD16) on human NK cells and neutrophils: cell-type specific expression of two genes which differ in single nucleotide substitutions. J. Exp. Med. 1989; 170: 481
   PubMed Web of Science ®Google Scholar
• Simmons, Seed B. The Fc receptor of natural killer cells is a phospholipid-linked membrane protein. Nature 1988; 333: 568
   PubMed Web of Science ®Google Scholar
• Peltz A. G., Grundy H. O., Lebo R. V., Yssel H., Barsh G. S., Moore K. W. Human FcγRIII: cloning, expression, and identification of the chromosomal locus of two Fc receptors for IgG. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 1013
   PubMed Web of Science ®Google Scholar
• Perussia B., Tutt M. M., Qiu W. Q., Kuziel W. A., Tucker P. W., Trinchieri G., Bennett M., Ravetch J. V., Kumar V. Murine natural killer cells express functional Fc receptor II encoded by the FcγRa gene. J. Exp. Med. 1989; 170: 73
   PubMed Web of Science ®Google Scholar
• Scallon J. B., Scigliano E., Freedman V. H., Miedel M. C., Pan Y.-C. E., Unkeless J. C., Kochan J. P. A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored forms. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 5079
   PubMed Web of Science ®Google Scholar
• Werner G., von dem Borne A. E. G. K., Bos M. J. E., Tromp J. F., van der Plas-van Dalen C. M., Visser F. J., Engelfriet C. P., Tetteroo P. A. T. Localization of the human NA1 alloantigen on neutrophil Fc-gamma receptors. Leukocyte Typing III, Vol. 3, Human Myeloid and Hematopoietic Cells, E. L. Reihertz, B. F. Haynes, L. M. Nadler, I. D. Bernstein. Springer-Verlag, New York 1988; 109
   Google Scholar
• Tetteroo P. A. T., van der Schoot C. E., Visser F. J., Bos M. J. E., von dem Borne A. E. G. K. Three different types of Fcγ receptors on human leukocytes defined by workshop antibodies: FcγRloW on neutrophils, FcγRlow of K/NK lymphocytes, and FcγRII. Leukocyte Typing III. White Cell Differentiation Antigens, A. J. McMichael. Oxford University Press, OxfordUK 1987; 702
   Google Scholar
• Fanger M. W., Shen L., Graziano R. F., Guyre P. M. Cytotoxicity mediated by human Fc receptors for IgG. Immunol. Today 1989; 10: 92
   PubMedGoogle Scholar
• Anderson P., Morimoto C., Breitmeyer J. B., Schlossman S. F. Regulatory interactions between members of the immunoglobulin superfamily. Immunol. Today 1988; 9: 199
   PubMedGoogle Scholar
• Miettinen H. M., Rose J. K., Mellman I. Fc receptor isoforms exhibit distinct abilities for coated pit localization as a result of cytoplasmic domain heterogeneity. Cell 1989; 58: 317
   PubMed Web of Science ®Google Scholar
• Kimberly R. P., Tappe N. J., Merriam L. T., Redecha P. B., Edberg J. C., Schwartzman S., Valinsky J. E. Carbohydrates on human Fcγ receptors. Independence of the classical IgG and non-classical lectin-binding sites on human Fcγ RIII expressed on neutrophils. J. Immunol. 1989; 142: 3923
   PubMed Web of Science ®Google Scholar
• Salmon J. E., Kapur S., Kimberly R. P. Opsonin-independent ligation of Fc receptors: the 3G8-bearing receptors on neutrophils mediate the phagocytosis of concanavalin A-treated erythrocytes and non-opsonize. Escherichia coli, J. Exp. Med. 1987; 166: 1798
   PubMed Web of Science ®Google Scholar
• Hoxie J. A., Mathews D. M., Callahan J., Cassel D. L., Cooper R. A. Transient modulation and internalization of T4 antigen induced by phorbol esters. J. Immunol. 1986; 137: 1194
   PubMed Web of Science ®Google Scholar
• Alcantra O., Phillips J. L., Bolt D. H. Phorbol diesters and transferrin modulate lymphoblastoid cell transferrin receptor expression by two different mechanisms. J. Cell. Physiol. 1986; 129: 329
   PubMed Web of Science ®Google Scholar
• Hunziker W., Koch T., Whitney J. A., Mellman I. Fc receptor phosphorylation during receptor-mediated B-cell activation. Nature (London) 1990; 345: 628
   PubMed Web of Science ®Google Scholar
• Sarmay G., Pecht I., Gergely J. Phosphorylation of type II Fcγ receptor on activated human B lymphocytes. Int. Immunol 1990; 2: 1235
   PubMed Web of Science ®Google Scholar
• Gergely J., Sarmay G. Production of soluble FcγR by activated B lymphocytes. Pathobiology, in press
   Google Scholar
• Okafor G. O., Turner M. W., Hay F. C. Localization of monocyte binding site of human immunoglobulin G. Nature (London) 1974; 248: 228
   PubMed Web of Science ®Google Scholar
• Alexander M. D., Andrews J. A., Leslie R. G. Q., Wood H. W. The binding of human and guinea pig IgG subclasses to homologous macrophages and monocyte receptors. Immunology 1978; 35: 115
   PubMed Web of Science ®Google Scholar
• Barnett-Foster D. E., Dorrington K. J., Painter R. H. Structure and function of immunoglobulin domains. VIII. An analysis of the structural requirements in human IgG1 for binding to the Fc receptor of human monocytes. J. Immunol. 1980; 124: 2186
   PubMed Web of Science ®Google Scholar
• Woof J. M., Nik Jaafar M. I., Jefferis R., Burton D. R. The monocyte binding domain(s) on human immunoglobulin G. Mol. Immunol. 1984; 21: 523
   PubMed Web of Science ®Google Scholar
• Ciccimara F., Rosen F. S., Merler E. Localisation of the IgG effector site for monocyte receptors. Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 2081
   PubMed Web of Science ®Google Scholar
• Ratcliffe A., Stanworth D. R. The use of synthetic gamma chain peptides in the localization of the binding site(s) on human IgG1 for the Fc receptors of homologous monocytes and heterologous mouse macrophages. Immunol. Lett. 1982; 4: 215
   PubMed Web of Science ®Google Scholar
• Nik Jaafar M. I., Lowe J. A., Ling N. R., Jefferis R. Immunogenic and antigenic epitopes of immunoglobulins. V. Reactivity of a panel of monoclonal antibodies with subfragments of human Fc and abnormal paraproteins having deletions. Mol. Immunol. 1982; 20: 679
   Web of Science ®Google Scholar
• Nik Jaafar M. I., Lowe J. A., Ling N. R., Jefferis R. Immunogenic and antigenic epitopes of immunoglobulins. VII. The topographical distribution of Fc epitopes and the relationship of an isoallotypic specificity to the presence of histidine 435. Mol. Immunol. 1984; 21: 137
   PubMed Web of Science ®Google Scholar
• Brüggemann M., Williams G. T., Bindon C. I., Clark M. R., Walker M. R., Jefferis R., Waldmann H., Neuberger M. S. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J. Exp. Med. 1987; 166: 1351
   PubMed Web of Science ®Google Scholar
• Jefferis R., Lund J., Pound J. Molecular definition of interaction sites on human IgG for Fc receptors (huFcγR). Mol. Immun. 1990; 27: 1237
   PubMed Web of Science ®Google Scholar
• Partridge L. J., Woof J. M., Jefferis R., Burton D. R. The use of anti-IgG monoclonal antibodies in mapping the monocyte receptor site for IgG. Mol. Immun. 1986; 23: 1365
   PubMed Web of Science ®Google Scholar
• Woof J. M., Partridge L. J., Jefferis R., Burton D. R. Localization of the monocyte-binding region on human immunoglobulin G. Mol. Immunol. 1986; 23: 319
   PubMed Web of Science ®Google Scholar
• Spiegelberg H. L., Perlmann H., Perlmann P. Interaction of K lymphocytes with myeloma proteins of different IgG subclasses. J. Immunol. 1976; 116: 1464
   Google Scholar
• Gergely J., Sarmay G. IgG-Fc-receptors: ligand binding and lysis induction. Immunol. Lett. 1989; 20: 1
   PubMed Web of Science ®Google Scholar
• Sarmay G., Benczur M., Petranyi G Y., Klein E., Kahn M., Stanworth D. R., Gergely J. Ligand inhibition studies on the role of Fc receptors in antibody-dependent cell-mediated cytotoxicity. Mol. Immunol 1984; 21: 43
   PubMed Web of Science ®Google Scholar
• Sarmay G., Jefferis R., Klein E., Benczur M., Gergely J. Mapping of the functional topography of Fc with monoclonal antibodies: localization of epitopes interacting with the binding sites of Fc receptors on human K cells. Eur. J. Immunol. 1985; 15: 1037
   PubMed Web of Science ®Google Scholar
• Erdei A., Benczur M., Fabry Zs., Dierich M. P., Gergely J. C3 cleaved by, membrane proteases binds to C3b acceptors expressed on Con A-stimulated human lymphocytes and enhances antibody dependent cellular cytotoxicity. Scand. J. Immunol 1984; 20: 125
   PubMed Web of Science ®Google Scholar
• Sarmay G., Jefferis R., Gergely J. CH2 and CH3 domain deleted IgG1 paraproteins inhibit differently Fc receptor mediated binding and lysis. Immunol. Lett. 1986; 12: 307
   PubMed Web of Science ®Google Scholar
• Rozsnyai Z., Sarmay G., Walker M., Maslanka K., Valasek Z., Jefferis R., Gergely J. Distinctive role of IgG1 and IgG3 isotypes in Fc R-mediated functions. Immunology 1989; 66: 491
   PubMed Web of Science ®Google Scholar
• Sarmay G., Rozsnyay Z., Gergely J. FcγRII expression and release on resting and activated human B lymphocytes. Mol. Immunol 1990; 27: 1195
   PubMed Web of Science ®Google Scholar
• Sarmay G., Istvan L., Gergely J. Shedding and reappearance of Fc, C3 and SRBC receptors on peripheral lymphocytes from normal donors and chronic lymphatic leukaemia (CLL) patients. Immunology 1978; 34: 315
   PubMed Web of Science ®Google Scholar
• Sandor M L, Füst G., Medgyesi G. A., Gergely J. Isolation and characterization of Fc receptor shed from human peripheral mononuclear blood cells. Immunology 1978; 35: 559
   PubMed Web of Science ®Google Scholar
• Uher F., Jancso A., Sandor M., Pinter K., Biro E., Gergely J. Interaction between actomyosin complexes and Fc receptors on human peripheral mononuclear cells. Immunol. Lett. 1981; 2: 213
   Web of Science ®Google Scholar
• Sarmay G., Benczur M., Petranyi G Y., Klein E., Kahn M., Stanworth D. R., Gergely J. Ligand inhibition studies on the role of Fc receptors in antibody-dependent cell-mediated cytotoxicity. Mol. Immunol 1984; 21: 43
   PubMed Web of Science ®Google Scholar
• Sandor M., Füst G., Medgyesi G. A., Erdei A., Gergely J. The heterogeneity of Fc receptors of human peripheral mononuclear cells. Immunology 1978; 38: 353
   Web of Science ®Google Scholar
• Sandor M., Füst G., Medgyesi G. A., Gergely J. Isolation and characterization of Fc receptor shed from human peripheral mononuclear blood cells. Immunology 1978; 35: 559
   PubMed Web of Science ®Google Scholar
• Sarmay G., Rozsnyai Z., Szabo I., Biro A., Gergely J. Modulation of type II Fcγ receptor expression on activated human B lymphocytes. Eur. J. Immunol 1991; 21: 241
   Web of Science ®Google Scholar
• Walker M. R., Woof J. M., Brüggemann M., Jefferis R., Burton D. R. Interaction of human chimeric antibodies with the human FcRI and FcRII receptors: requirements for antibody-mediated host-target cell interaction. Mol. Immunol 1989; 26: 403
   PubMed Web of Science ®Google Scholar
• Salmon J. E., Kimberly R. P. Phagocytosis of concanavalin A-treated erythrocytes is mediated by the Fcγ receptor. J. Immunol 1986; 137: 456
   PubMed Web of Science ®Google Scholar
• Fridman W. H., Golstein P. Immunoglobulin-binding factor present on and produced by thy-mus-processed lymphocytes (T cells). Cell. Immunol 1974; 11: 424
   Web of Science ®Google Scholar
• Fridman W. H., Sautes C. Immunoglobulin-binding factors. Fc Receptors and the Action of Antibodies, H. Metzger. Telford Press, Caldwell, NJ 1990; 335
   Google Scholar
• Le Thui Thi Bich, Samarut C., Brochier J., Fridman W. H., Revillard J. P. Suppression of mitogen induced peripheral B cell differentiation by soluble receptors for Fc IgG released from lymphocytes. Eur. J. Immunol 1980; 10: 894
   PubMed Web of Science ®Google Scholar
• Neauport-Sautes C., Dupuis D., Fridman W. H. Specificity of Fc receptors on activated T cells. Relation with released immunoglobulin binding factor. Eur. J. Immunol 1975; 5: 849
   Web of Science ®Google Scholar
• Pure E., Durie C. J., Summerill C. K., Unkeless J. C. Identification of soluble Fc receptors in mouse serum and the conditioned medium of stimulated B cells. J. Exp. Med. 1984; 160: 1836
   PubMed Web of Science ®Google Scholar
• Calvo C., Watanabe F., Metivier D., Senik A. Human monocyte-cell line U937 releases suppressive IgG BF. Eur. J. Immunol 1986; 16: 25
   PubMed Web of Science ®Google Scholar
• Le Thui Thi Bich, Samarut C., Rabourdin-Combe C., Revillard J. P. The suppressive activity of FcγRs is not related to their T cell origin. Cell. Immunol 1982; 68: 252
   PubMed Web of Science ®Google Scholar
• Fridman W. H. Ed., Structures and functions of low affinity Fc receptors. Chem. Immunol. 1989; 47
   PubMedGoogle Scholar
• Daeron M., Neauport-Sautes C., Yodoi J., Moncuit J., Fridman W. H. Receptors for immunoglobulin isotypes (FcR) on murine T cells. II. Multiple FcR induction on hybridoma T cell clones. Eur. J. Immunol 1985; 15: 668
   PubMed Web of Science ®Google Scholar
• Hoover R. G., Gebel H. M., Dieckgraefe B. K., Hickman S., Rebbe N. F., Hirayama N., Ovary Z., Lynch R. G. Occurrence and potential significance of increased number of T cells with Fc receptors in myeloma. Immunol. Rev. 1981; 56: 115
   PubMed Web of Science ®Google Scholar
• Khayat D., Dux Z., Anavi R., Shlomo Y., Witz I. P., Ran M. Circulating cell free Fcγ2b/1 receptor in normal mouse serum: its detection and specificity. J. Immunol 1984; 132: 2496
   PubMed Web of Science ®Google Scholar
• Khayat D., Geffrier C., Yoon S., Scigliano E., Soubran C., Weil M., Unkeless J. C. Soluble circulating Fcγ receptor in human serum, a new ELISA assay for specific and quantitative detection. J. Immunol. 1987; 100: 235
   Google Scholar
• Sarfati M., Bron D., Lagneaux L., Fonteyn C., Frost H., Delespesse G. Elevation of Ige-binding factors in serum of patients with B-cell derived chronic lymphoid leukemia. Blood 1988; 71: 94
   PubMed Web of Science ®Google Scholar
• Blank U., Daeron M., Galinha A., Fridman W. H., Sautes C. The carbohydrate moieties of suppressor IgG binding factor released by murine T cells. Mol. Immunol 1987; 24: 1061
   PubMed Web of Science ®Google Scholar
• Blank U., Daeron M., Galinha A., Malard V., Fridman W. H., Sautes C. Identification of the FcγRII related component of murine IgG-BF. Mol. Immunol 1989; 26: 107
   PubMed Web of Science ®Google Scholar
• Daeron M., Neauport-Sautes C., Blank U., Fridman W. H. 2.4G2 a monoclonal antibody to macrophage Fcγ receptors reacts with murine T cell Fcγ receptors and IgG-binding factors. Eur. J. Immunol 1986; 16: 1545
   PubMed Web of Science ®Google Scholar
• Sautes C., Varin N., Hogarth P. M., Unkeless J. C., Teillaud C., Even J., Lynch A., Fridman W. H. Molecular and functional studies of recombinant soluble Fcγ receptors. Mol. Immunol 1990; 27: 1201
   PubMed Web of Science ®Google Scholar
• Levinson A. I., Martin J. Rheumatoid factor: Dr. Jekyll or Mr. Hyde. Br. J. Rheum. 1988; 27: 83
   PubMedGoogle Scholar
• Poncet P., Matthes T., Billecoco A., Dighiero G. Immunochemical studies of poly specific natural autoantibodies: charge, lipid reactivity, F(ab')2 fragment activity and complement fixation. Mol. Immunol 1988; 25: 981
   PubMed Web of Science ®Google Scholar
• Heller G., Kolodny M. H., Lepow I. H., Jacobson A. S., Rivera M. E., Marks G. H. The haemagglutination test for rheumatoid arthritis. IV. Characterization of the rheumatoid agglutinating factors by analysis of serum fractions prepared by ethanol fractionation. J. Immunol 1955; 74: 340
   PubMed Web of Science ®Google Scholar
• Hartman A. B., Mallett C. P., Srinivasappa J., Prabhakar B. S., Notkins A. L., Smith-Gill S. J. Organ reactive autoantibodies from non-immunized adult Ba1b/c mice are polyreactive and express non-biased VH gene usage. Mol. Immunol. 1989; 26: 359
   PubMed Web of Science ®Google Scholar
• Rousseau P. G., Mallett C. P., Smith-Gill S. J. A substantial proportion of the adult Ba1b/c available B cell repertoire consists of multireactive B cells. Mol. Immunol 1989; 26: 003
   Web of Science ®Google Scholar
• Lydyard P. M., Quartey-Papafio R., Bröker B., Mackenzie L., Jouquan J., Blaschek M. A., Steele J., Petrou M., Collins P., Isenberg D., Youinou P. Y. The antibody repertoire of early human B cells. I. High frequency of autoreactivity and polyreactivity. Scand. J. Immunol 1990; 31: 33
   PubMed Web of Science ®Google Scholar
• Fernandez P.-A., Ternyck T., Avrameas S. Immunochemical studies of a murine polyreactive IgG2b autoantibody with rheumatoid factor activity. Mol Immunol 1989; 26: 539
   PubMed Web of Science ®Google Scholar
• Shlomshik M. J., Nemazee D. A., Sato V. I., Van Snick J., Carson D. A., Weigert M. Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells. J. Exp. Med. 1986; 164: 407
   PubMed Web of Science ®Google Scholar
• Manheimer-Lory A. J., Monestier M., Bellon B., Alt F. W., Bona C. A. Fine specificity, idiotypy, and nature of cloned heavy-chain variable region genes of murine monoclonal rheumatoid factor antibodies. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 8293
   PubMed Web of Science ®Google Scholar
• Monestier M., Manheimer-Lory A., Bellon B., Painter C., Dang H., Talal N., Zanetti M., Schwartz R., Pisetsky D., Kuppers R., Rose N., Brochler J., Klareskog L., Holmdahl R., Erlanger B., Alt F., Bona C. Shared idiotypes and restricted immunoglobulin variable region heavy chain genes characterize murine autoantibodies of various specificities. J. Clin. Invest. 1986; 78: 753
   PubMed Web of Science ®Google Scholar
• Burastero S. E., Casali P., Wilder R., Notkins A. L. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J. Exp. Med. 1988; 168: 1979
   PubMed Web of Science ®Google Scholar
• Nakamura M., Burastero S. E., Notkins A. L., Casali P. Human monoclonal rheumatoid factor-like antibodies from CD5+ (Leu-1)+ B cells are polyreactive. J. Immunol 1988; 140: 4180
   PubMed Web of Science ®Google Scholar
• Hayakawa K., Hardy R. R., Honda M., Herzenberg L., Steinberg A. D., Herzenberg L. A. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc. Natl Acad. Sci. U.S.A. 1984; 81: 2494
   PubMed Web of Science ®Google Scholar
• Hardy R. R., Hayakawa K., Shimizu M., Yamasaki K., Kishimoto T. Rheumatoid factor secretion from human Leu-1+ B cells. Science 1987; 236: 81
   PubMed Web of Science ®Google Scholar
• Pereira P., Coutinho A. I-E-linked control of spontaneous rheumatoid factor production in normal mice. J. Exp. Med. 1989; 170: 1825
   PubMed Web of Science ®Google Scholar
• Van Snick J. L., Masson P. L. Age-dependent production of IgA and IgM autoantibodies against IgG2a in a colony of 129/Sv mice. J. Exp. Med. 1979; 149: 1519
   PubMed Web of Science ®Google Scholar
• Van Snick J. L., Masson P. L. Incidence and specificities of IgA and IgM anti-IgG autoantibodies in various mouse strains and colonies. J. Exp. Med. 1980; 151: 45
   PubMed Web of Science ®Google Scholar
• Van Snick J. A gene linked to the IgG-C locus controls the production of rheumatoid factor in the mouse. J. Exp. Med. 1981; 153: 738
   PubMed Web of Science ®Google Scholar
• Dresser D. W. Most IgM-producing cells in the mouse secrete autoantibodies (rheumatoid factor). Nature 1978; 274: 480
   PubMed Web of Science ®Google Scholar
• Vischer T. L. Neutral proteinases induce rheumatoid factor production in mouse spleen cell cultures. Clin. Exp. Immunol. 1984; 55: 99
   PubMed Web of Science ®Google Scholar
• Dziarski R. Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. J. Immunol. 1982; 128: 1018
   PubMedGoogle Scholar
• Dziarski E. Anti-immunoglobulin autoantibodies are not preferentially induced in polyclonal activation of human and mouse lymphocytes, and more anti-DNA and anti-erythrocyte autoantibodies are induced in polyclonal activation of mouse than human lymphocytes. J. Immunol. 1984; 133: 2537
   PubMed Web of Science ®Google Scholar
• Levinson A. I. Nature of stimulus for rheumatoid factor production. Autoantibodies to Immunoglobulins, F. Shakib. S. Karger, Basel 1989; 26, Monogr. Allergy
   Google Scholar
• Shokri F., Mageed R. A., Maziak B. R., Jefferis R. Expression of VHIII-associated cross-reactive idiotype on human B lymphocytes. Association with staphylococcal protein A binding and Staphylococcus aureus Cowan I stimulation. J. Immunol. 1991; 146: 936
   PubMed Web of Science ®Google Scholar
• Izui S., Kelley V. E., Masuda K., Yoshida H., Roths J. B., Murphy E. D. Induction of various autoantibodies by mutant gene 1pr in several strains of mice. J. Immunol. 1984; 133: 227
   PubMed Web of Science ®Google Scholar
• Carson D. A. Rheumatoid factor. Textbook of Rheumatology, W. N. Kelly, E. D. Harris, S. Ruddy. W. B. Saunders, Philadelphia 1985; 664
   Google Scholar
• Carson D. A., Chen P. P., Fox R. I., Kipps T. J., Jirik F., Godfien R. D., Silverman G., Radoux V., Fong S. Rheumatoid factor and immune networks. Ann. Rev. Immunol. 1987; 5: 109
   PubMed Web of Science ®Google Scholar
• Hang L. M., Theofilopoulos A. N., Dixon F. J. A spontaneous rheumatoid arthritis-like disease in MRL/1 mice. J. Exp. Med. 1982; 155: 1690
   PubMed Web of Science ®Google Scholar
• Aho K., Wager O. Production of “anti-antibodies” in rabbits. Appearance in rabbit serum of “anti-antibodies” reacting with autogenous and isogenous antibody, following autostimulation with protein antigens. Ann. Med. Exp. Fenn. 1961; 39: 79
   PubMedGoogle Scholar
• Van Snick J., Coulie P. Rheumatoid factors and secondary immune responses in the mouse. Eur. J. Immunol 1983; 13: 890
   PubMed Web of Science ®Google Scholar
• Coulie P., Van Snick J. Rheumatoid factors and secondary immune responses in the mouse. II. Incidence, kinetics and induction mechanisms. Eur. J. Immunol. 1983; 13: 895
   PubMed Web of Science ®Google Scholar
• Nemazee D. A., Sato V. L. Induction of rheumatoid antibodies in the mouse. Regulated production of autoantibody in the secondary humoral response. J. Exp. Med. 1983; 158: 529
   PubMed Web of Science ®Google Scholar
• Stanley S. I., Bishoff J., Davie J. M. Antigen induced rheumatoid factors: protein and carbohydrate antigens induce different rheumatoid factor responses. J. Immunol. 1987; 139: 2936
   PubMed Web of Science ®Google Scholar
• Stanley S. L., Jr., Li E., Davie J. M. Antigen induced rheumatoid factors: characteristics of monoclonal rheumatoid factors produced after protein and carbohydrate immunization. Mol. Immunol. 1988; 25: 285
   PubMed Web of Science ®Google Scholar
• Nemazee D. A. Immune complexes can trigger specific, T cell-dependent autoanti-IgG antibody production in mice. J. Exp. Med. 1985; 161: 242
   PubMed Web of Science ®Google Scholar
• Coulie P., Van Snick J. Rheumatoid factor (RF) production during anamnestic immune response in the mouse, in. Activation of RF precursor cells is induced by their interaction with immune complexes and carrier-specific helper T cells. J. Exp. Med. 1985; 161: 88
   PubMed Web of Science ®Google Scholar
• Holmdahl R., Klageskog L., Anderson M., Hansen C. High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics 1986; 24: 84
   PubMed Web of Science ®Google Scholar
• Casali P., Burastero S. E., Balow J. E., Notkins A. L. High affinity antibodies to ssDNA are produced by CD− B cells in systemic lupus erythematosus patients. J. Immunol. 1989; 143: 3476
   PubMed Web of Science ®Google Scholar
• Tarkowski A., Czerkinsky C., Nilsson L.-A. Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study. Clin. Exp. Immunol 1984; 58: 7
   PubMed Web of Science ®Google Scholar
• Izui S., Eisenberg R. A. Circulating anti-DNA-rheumatoid factor complexes in MRL/1 mice. Clin. Immunol. Immunopathol 1980; 15: 536
   PubMedGoogle Scholar
• Fazekas Gy., Rajnavölgyi E., Kurucz I., Sintar E., Kiss K., Laszlo G., Gergely J. Isolation and characterization of IgG2a-reactive autoantibodies from influenza virus-infected BALB/c mice. Eur. J. Immunol 1990; 20: 2719
   PubMed Web of Science ®Google Scholar
• Paavonen T., Quartey-Papalio R., Delyes P. J., Mackenzie L., Lund T., Youinou P., Lydyard P. M. CD5 mRNA expression and autoantibodies in early human B cells immortalized by EBV. Scand. J. Immunol 1990; 31: 269
   PubMed Web of Science ®Google Scholar
• Taguchi H., Kanoh M., Takubo N., Kadota S., Kanazawa K., Hitsumoto V., Shirata T., Utsumi S. IgG isotype and isotype specificity of murine monoclonal IgG rheumatoid factors. Clin. Exp. Immunol 1990; 80: 136
   PubMed Web of Science ®Google Scholar
• Shlomshik M., Nemazee D., Van Snick J., Weigert M. Variable region sequence of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors): II. Comparison of hybridomas derived by lipopolysaccharide stimulation and secondary protein immunization. J. Exp. Med. 1987; 165: 970
   PubMed Web of Science ®Google Scholar
• Shlomshik M. J., Marshak-Rothstein A., Wolfowicz C. B., Rothstein T. L., Weigert M. G. The role of clonal selection and somatic mutation in autoimmunity. Nature 1987; 328: 805
   PubMed Web of Science ®Google Scholar
• Jefferis R., Mageed R. A. The specificity and reactivity of rheumatoid factors with human IgG. Autoantibodies to Immunoglobulins, F. Shakib. Monogr. Allergy, S. Karger, Basel 1989; 26
   Google Scholar
• Pisetsky D. S., Darwin B. S., Reich C. F. IgG binding of monoclonal anti-nuclear antibodies from MLR-1pr mice. Immunology 1990; 71: 586
   PubMed Web of Science ®Google Scholar
• Holmdahl R., Nordling C., Rubin K., Tarkowski A., Klareskog L. Generation of rheumatoid factors after immunization with collagen type II-anti-collagen II immune complexes. An anti-idiotypic antibody to anti-collagen II is also rheumatoid factor. Scand. J. Immunol. 1986; 24: 197
   PubMed Web of Science ®Google Scholar
• Bona C. A. Epibodies. A particular set of anti-idiotypes specific for autoantibodies. Clin. Immunol. Newsl. 1985; 6: 87
   Google Scholar
• Chen P. P., Fong S., Houghten R. A., Carson D. A. Characterization of an epibody. An anti-idiotype that reacts with both the idiotype of rheumatoid factors (RF) and the antigen recognized by RF. J. Exp. Med. 1985; 161: 323
   PubMed Web of Science ®Google Scholar
• Johnson P. M., Phua K. K., Evans H. B. An idiotypic complementary between rheumatoid factor and antipeptidoglycan antibodies. Clin. Exp. Immunol. 1985; 61: 373
   PubMed Web of Science ®Google Scholar
• Nardella F. A., Teller D. C., Barber C. B., Mannik M. IgG rheumatoid factors and staphylococcal protein A bind to common molecular region on IgG. J. Exp. Med. 1985; 162: 1811
   PubMed Web of Science ®Google Scholar
• Nardella F. A., Schröder A. K., Svensson M.-L., Sjöquist J., Barber C., Christensen P. T15 group A streptococcal Fc receptor binds to the same location on IgG as staphylococcal protein A and IgG rheumatoid factors. J. Immunol. 1987; 140: 922
   Google Scholar
• Sasso E. H., Barber C. V., Nardella F. A., Yount W. J., Mannik M. Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors. J. Immunol. 1988; 140: 3098
   PubMed Web of Science ®Google Scholar
• Huck S., Fort P., Crawford D. H., Lefranc M.-P., Lefranc G. Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human C genes. Nucl. Acids Res. 1986; 14: 1779
   PubMed Web of Science ®Google Scholar
• Artandi S. E., Canifieid S. M., Tao M.-H., Calame K. L., Morrison S. L., Bonagura V. R. Molecular analysis of IgM rheumatoid factor binding to chimeric IgG. J. Immunol 1991; 146: 603
   PubMed Web of Science ®Google Scholar
• Parekh R. B., Dwek R. A., Sutton B. J., Fernandes D. L., Leung A., Stanworth D. R., Rademacher T. W., Mizouchi T., Taniguchi T., Matsuta K., Takeuchi F., Nagano Y., Miyamoto T., Kobata A. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316: 452
   PubMed Web of Science ®Google Scholar
• Axford J. S., Mackanzie L., Lydyard P. M., Hay F. C., Isenberg D. A., Roitt I. M. Reduced B cell galactosyltransferase activity in rheumatoid arthritis. J. Immunol. 1988; 140: 3098
   PubMedGoogle Scholar
• Newkirk M. M., Lemmo A., Rauch J. Importance of the IgG isotype, not the state of glycosylation, in determining human rheumatoid factor binding. Arth. Rheum. 1990; 33: 800
   PubMedGoogle Scholar
• Van Snick J., Stassin V., de Lestre B. Isotypic and allotypic specificity of mouse rheumatoid factors. J. Exp. Med. 1983; 157: 1006
   PubMed Web of Science ®Google Scholar
• Aguado M. T., Balderas R. S., Rubin R. L., Duchosal M. A., Kofler R., Birshtein B. K., Secher D. S., Dixon F. J., Theofilopoulos A. N. Specificity and molecular characteristics of monoclonal IgM rheumatoid factors from arthritic and non-arthritic mice. J. Immunol. 1987; 139: 1080
   PubMed Web of Science ®Google Scholar
• Stassin V., Coulie P., Birshtein B., Secher D., Van Snick J. Determinants recognized by murine rheumatoid factors: molecular localization using a panel of mouse myeloma variant immunoglobulins. J. Exp. Med. 1983; 158: 1763
   PubMed Web of Science ®Google Scholar
• Izui S., Eisenberg R. A., Dixon F. J. IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. J. Immunol. 1979; 122: 2096
   PubMed Web of Science ®Google Scholar
• Tarkowski A., Holmdahl R., Klageskog L. Rheumatoid factors in mice. Autoantibodies to Immunoglobulins, F. Shakib. Monogr. Allergy, S. Karger, Basel 1989; 26
   Google Scholar
• Coutelier J.-P., Van der Logt J. T. M., Hessen F. W. A., Vink A., Warnier G., Van Snick J. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 1987; 165: 64
   PubMed Web of Science ®Google Scholar
• Coutelier J.-P., Van der Logt J. T. M., Hessen F. W. A., Vink A., Van Snick J. Virally induced modulation of murine IgG subclasses. J. Exp. Med. 1988; 168: 2373
   PubMed Web of Science ®Google Scholar
• Rajnavölgyi E., Fazekas Gy., Daeron M., Teillaud J.-L., Fridman W. H., Jefferis R., Gergely J. Fine specificity and functional properties of rheumatoid factor-like autoantibodies isolated from influenza virus infected Ba1b/c mice, unpublished manuscript
   Google Scholar
• Nardella F. A., Teller D. C., Mannik M. Studies on the antigenic determinants in the self-association of IgG rheumatoid factor. J. Exp. Med. 1981; 154: 112
   PubMed Web of Science ®Google Scholar
• Robbins D. L., Skilling J., Benisek W. F., Wistar R. Estimation of the relative avidity of 19S IgM rheumatoid factor secreted by rheumatic synovial cells for human IgG subclasses. Arth. Rheum. 1986; 29: 722
   PubMedGoogle Scholar
• Easterbrook-Smith S. B., Vandenberg R. J., Alden J. R. The role of Fc:Fc interactions in insoluble immune complex formation and complement activation. Mol. Immunol 1988; 25: 1331
   PubMed Web of Science ®Google Scholar
• Klaasen R. J. L., Goldschmeding R., Tetteroo P. A. T., von dem Borne A. E. G. K. The Fc valency of an immune complex is the decisive factor for binding to low-affinity Fc receptors. Eur. J. Immunol 1988; 18: 1373
   PubMed Web of Science ®Google Scholar
• Jungi T. W., Lerch P. G., Cachelin A. B., Morell A. Monomelic and dimeric IgG1 as probes for assessing high-affinity and low-affinity receptors for IgG on human monocyte derived macrophages and on activated macrophages. Mol. Immunol 1985; 55: 555
   Google Scholar
• Doekes G., Schouten J., Cats A., Dana M. R. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor. Immunology 1985; 55: 555
   PubMed Web of Science ®Google Scholar
• Doekes G., Hiemstra P. S. Rheumatoid factor and complement activation. Autoantibodies to Immunoglobulins, F. Shakib. Monogr. Allergy, S. Karger, Basel 1989; 26
   Google Scholar
• Rajnavölgyi E., Reth M., Uher F., Miklos K., Gergely J., Rajewsky K. Fc-dependent effector functions of idiotype-anti-idiotype immune complexes. Mol. Immunol. 1984; 21: 127
   PubMed Web of Science ®Google Scholar
• Tesar J. T., Schmid F. R. Conversion of soluble immune complexes into complement-fixing aggregates by IgM-rheumatoid factor. J. Immunol. 1970; 105: 1206
   PubMed Web of Science ®Google Scholar
• Tanimoto K., Cooper N. R., Johnson J. S., Vaughan J. H. Complement fixation by rheumatoid factor. J. Clin. Invest. 1975; 55: 437
   PubMed Web of Science ®Google Scholar
• Doekes G., Van Es L. A., Daha M. R. Activation of C1q by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures proenzyme form of C1s. J. Immunol. 1983; 131: 1924
   PubMed Web of Science ®Google Scholar
• Feinstein A., Richardson N. E., Gorick B. D., Hugh-Jones N. C. Immunoglobulin M conformational change is a signal for complement activation. Protein Conformation as an Immunological Signal, F. Celada, V. N. Schumaker, E. E. Sercarz. Plenum Press, New York 1983; 47
   Google Scholar
• Chestnut R. W., Colon S. M., Grey H. M. Requirements for the processing of antigens by antigen-presenting B cells. I. Functional comparison of B cell tumors and macrophages. J. Immunol. 1982; 129: 2382
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A. Antigen uptake and accumulation in antigen-specific B cells. Immunol. Rev. 1987; 99: 39
   PubMed Web of Science ®Google Scholar
• DeFranco A. L., Gold M. R., Jakway J. P. B-lymphocyte signal transduction in response to anti-immunoglobulin and bacterial lipopolysaccharide. Immunol. Rev. 1987; 95: 161
   PubMed Web of Science ®Google Scholar
• Cambier J. C., Ransom J. T. Molecular mechanisms of transmembrane signalling in B lymphocytes. Annu. Rev. Immunol. 1987; 5: 175
   PubMed Web of Science ®Google Scholar
• Klaus G. G. B., Bijsterbosch M. K., O'Garra A., Harnett M. H., Rigley K. P. Receptor signalling and crosstalk in B lymphocytes. Immunol. Rev. 1987; 99: 19
   PubMed Web of Science ®Google Scholar
• McDougall S. L., Grinstein S., Gelfand E. W. Activation of Ca++ dependent K+ channels in human B lymphocytes by anti-immunoglobulins. J. Clin. Invest. 1988; 81: 449
   PubMed Web of Science ®Google Scholar
• Ransom J. T., Cambier J. C. The dynamics of K+ efflux and Ca2+ influx in B lymphocytes following antigen receptor crosslinking. Proc. Soc. Gen. Physiol., in press
   Google Scholar
• Amigorena S., Choquet D., Teillaud J.-L., Korn H., Fridman W. H. Ion channels and B cell mitogenesis. Mol. Immunol 1990; 27: 1259
   PubMed Web of Science ®Google Scholar
• Ingles J., Engel P., De La Calle O., Gallart T. Differential responsiveness of human B lymphocytes to phorbol ester and calcium ionophore based on their state of activation. Immunology 1989; 67: 359
   PubMed Web of Science ®Google Scholar
• Lenhardt W., Karasuyama H., Rolink A., Melchers F. Control of the cycle of murine B 11 of α- and β-growth factors and of B cell maturation factors. Immunol. Rev. 1987; 99: 241
   PubMed Web of Science ®Google Scholar
• Melchers F., Lenhardt W. Three restriction points in the cell cycle of activated murine B lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 7681
   PubMed Web of Science ®Google Scholar
• Janeway C. A., Jr., Bottomly K., Babich J., Conrad P., Conzen S., Jones B., Kaye J., Katz M., McVay L., Murphy D. B., Tite J. Quantitative variation in la antigen expression plays a central role in immune regulation. Immunol. Today 1984; 5: 99
   PubMedGoogle Scholar
• Melchers F., Erdei A., Schultz T., Dierich M. P. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature (London) 1985; 317: 264
   PubMed Web of Science ®Google Scholar
• Howard M., Paul W. E. Regulation of B cell growth and differentiation by soluble factors. Ann. Rev. Immunol. 1983; 1: 307
   PubMed Web of Science ®Google Scholar
• Barrett T. B., Shu G. L., Draves K. E., Pezutto A., Clark E. A. Signaling through CD19, Fc receptors or transforming growth factor-β: each inhibits the activation of resting human B cells differently. Eur. J. Immunol. 1990; 20: 1053
   PubMed Web of Science ®Google Scholar
• Pezzutto A., Dörken B., Rabinovich P. S., Ledbetter J. A., Moldenhauer G., Clark E. A. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin induced B cell activation and proliferation. J. Immunol. 1987; 138: 2793
   PubMed Web of Science ®Google Scholar
• Sinclair N. R. S., Chan P. L. Regulation of the immune response. IV. The role of the Fc-fragment in feedback inhibition by antibody. Adv. Exp. Biol. 1971; 12: 609
   Google Scholar
• Uhr J. W., Möller G. Regulatory effect of antibody on the immune response. Adv. Immunol. 1968; 8: 81
   PubMedGoogle Scholar
• Abrahams S., Phillips R. S., Miner R. A. Inhibition of the immune response by tS antibody. Mechanism and site of action. J. Exp. Med. 1973; 137: 870
   PubMed Web of Science ®Google Scholar
• Ryan J. L., Henkart P. A. Fc receptor mediated inhibition of murine B lymphocyte activation. J. Exp. Med. 1976; 144: 768
   PubMed Web of Science ®Google Scholar
• Kölsch E., Oberbarnscheidt J., Bruner K., Heuer J. The Fc-receptor: its role in the transmission of differentiation signals. Immunol. Rev. 1980; 49: 61
   PubMed Web of Science ®Google Scholar
• Uher F., Dickler H. B. Independent ligand occupancy and cross-linking of surface Ig and Fc receptors downregulates B-lymphocyte function. Evaluation in various B-lymphocyte populations. Mol. Immunol 1985; 23: 1177
   Web of Science ®Google Scholar
• Waldschmidt T. J., Vitetta E. S. Fc receptors on B cells mediate down regulation of antibody secretion. Ann. Immunol. 1985
   Google Scholar
• Phillips N. E., Parker D. C. Crosslinking of B lymphocytes, Fcγ receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J. Immunol. 1984; 132: 627
   PubMed Web of Science ®Google Scholar
• Bijsterbosch M. K., Klaus G. G. Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors. J. Exp. Med. 1985; 162: 1825
   PubMed Web of Science ®Google Scholar
• Rigley K. P., Harnett M. M., Klaus G. G. B. Co-cross-linking of surface immunoglobulin Fcγ receptors on B lymphocytes uncouples the antigen receptors from their associated G protein. Eur. J. Immunol. 1989; 19: 481
   PubMed Web of Science ®Google Scholar
• Tsokos G. C., Kinoshita T., Thyphronitis G., Patel A. D., Didder H. B., Finkelman F. D. J. Immunol. 1990; 144: 239
   PubMed Web of Science ®Google Scholar
• Carter R. H., Spycher M. O., Yin C. N. G., Hoffman R., Fearon D. T. Synergistic interaction between complement receptors type 2 and membrane IgM on B lymphocytes. J. Immunol. 1988; 141: 457
   PubMed Web of Science ®Google Scholar
• Wiersma E. J., Coulie P. G., Heyman B. Dual immunoregulatory effects of monoclonal IgG-antibodies: suppression and enhancement of the antibody response. Scand. J. Immunol 1989; 29: 439
   PubMed Web of Science ®Google Scholar
• Heyman B. Fc-dependent IgG-mediated suppression of the antibody response: fact or artifact. Immunol. Today 1990; 11: 310
   PubMedGoogle Scholar
• Marcelletti J. F., Katz D. H. FcR+ lymphocytes and the regulation of the IgE antibody system. I. A new class of molecules termed IgE-induced regulants (EIR) which modulate FcR expression by lymphocytes. J. Immunol 1984; 133: 2821
   PubMed Web of Science ®Google Scholar
• Bonnefoy J. Y., Defrance T., Peronne C., Menetrier C., Pene J., de Vries J.-E., Bancherau J. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgR binding factor analogous to that spontaneously released by lymphoblastoid B cell lines. Eur. J. Immunol 1988; 18: 117
   PubMed Web of Science ®Google Scholar
• Delespesse G. M., Sarfati M., Hofstetter H. Human IgE-binding factors. Immunol. Today 1989; 10: 159
   PubMedGoogle Scholar
• Gordon J., Flores-Romo L., Cairns J. A., Millsum M. J., Lane P. J., Johnson G. D., McClennan I. C. M. CD23: a multifunctional receptor/lymphokine. Immunol. Today 1989; 10: 153
   PubMedGoogle Scholar
• Amin A. R., Coico R. F., Finkelman F., Siskind G. W., Thorbecke G. J. Release of IgD-binding factor by T cells under the influence of interleukin 2, interleukin 4, or cross-linked IgD. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 9179
   PubMed Web of Science ®Google Scholar
• Fridman W. H., Gresser I., Bandu M. T., Aguet M., Neauport-Sautes C. Interferon enhances the expression of Fcγ receptors. J. Immunol 1980; 124: 2436
   PubMed Web of Science ®Google Scholar
• Daeron M., Yodoi J., Neauport-Sautes C., Moncuit J., Fridman W. H. Receptors for immunoglobulin isotypes (FcR) on murine T cells. I. Multiple FcR expression on T lymphocytes and hybridoma T cell clones. Eur. J. Immunol. 1985; 15: 662
   PubMed Web of Science ®Google Scholar
• Hoover R. G., Dieckgraefe B. H., Lynch R. G. T cells with Fc receptors for IgA: induction of T cells in vivo by purified IgA. J. Immunol 1981; 127: 1560
   PubMed Web of Science ®Google Scholar
• Mathur A., Lynch R. G. Increased Tγ and Tμ, cells in Ba1b/c mice with IgG and IgM plasmacytomas and hybridomas. J. Immunol 1986; 136: 521
   PubMed Web of Science ®Google Scholar
• Daeron M., Bonnerot C., Sandor M., Varin N., Hogarth P. M., Even J., Fridman W. H. Molecular mechanisms regulating the expression of murine T cell Fcγ receptor II. Mol. Immunol. 1988; 25: 1143
   PubMed Web of Science ®Google Scholar
• Brunati S., Moncuit J., Fridman W. H., Teillaud J.-L. Regulation of IgG production by suppressor FcγRII+ T hybridomas. Eur. J. Immunol 1990; 20: 55
   PubMed Web of Science ®Google Scholar
• Varin N., Sautes C., Galinha A., Even J., Hogarth P. M., Fridman W. H. Recombinant soluble receptors for the Fcγ portion inhibit antibody productio. in vitro, Eur. J. Immunol 1989; 19: 2263
   PubMed Web of Science ®Google Scholar
• Bonnerot C., Daeron M., Varin N., Amigorena S., Hogarth P. M., Even J., Fridman W. H. Methylation in the 5′ region of the murine βFcγR gene regulates the expression of the Fcγ receptor II. J. Immunol 1988; 141: 1026
   PubMed Web of Science ®Google Scholar
• Daeron M., Bonnerot C., Latour S., Benhamou M., Fridman W. H. The murine αFeγR gene product: identification, expression, and regulation. Mol. Immunol 1990; 27: 1181
   PubMed Web of Science ®Google Scholar
• Weinshank R. L., Luster A. D., Ravetch J. V. Function and regulation of a murine macrophage-specific IgG Fc receptor, FcγR-α. J. Exp. Med. 1988; 167: 1909
   PubMed Web of Science ®Google Scholar
• Yokota A., Kikutani H., Tanaka T., Sato R., Barsumian E. L., Suemura M., Kishimoto T. Two species of human FcR H (FcRII/CD23): tissue specific and interleukin-4 specific regulation of the gene expression. Cell 1988; 55: 611
   PubMed Web of Science ®Google Scholar
• Laszlo G., Dickler H. B. IL-4 induces loss of B lymphocyte FcγRII ligand binding capacity. J. Immunol 1988; 141: 3416
   PubMed Web of Science ®Google Scholar
• O'Garra A., Rigley K. P., Holman M., McLaughlin J. B., Klaus G. G. B cell stimulatory factor 1 reverses Fc receptor-mediated inhibition of B lymphocyte activation. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 6254
   PubMed Web of Science ®Google Scholar
• Amigorena S., Bonnerot C., Choquet D., Fridman W. H., Teillaud J.-L. FcγRII expression in resting and activated B lymphocytes. Eur. J. Immunol 1989; 19: 1379
   PubMed Web of Science ®Google Scholar
• Gordon J., Flores-Romo L., Cairns J. A., Millsum M. J., Lane P. J., Johanson G. D., McClennan I. C. CD23: a multifunctional receptor/lymphokine. Immunol. Today 1989; 10: 153
   PubMedGoogle Scholar
• Gordon J., Webb A., Walker L., Guy G. R., Rowe M. Evidence for an association between CD23 and the low molecular weight B cell growth factor. Eur. J. Immunol. 1986; 16: 1627
   PubMed Web of Science ®Google Scholar
• Hivroz C., Valle A., Brouet J. C., Banchereau J., Grillot-Courvalin C. Regulation by inter-leukin-2 of CD23 expression of leukemic and normal B cells: comparison with interleukin-4. Eur. J. Immunol. 1989; 19: 1025
   PubMed Web of Science ®Google Scholar
• Letellier M., Sarfati M., Delespesse G. Mechanisms of formation of IgE-binding factors (soluble CD23). I. FcRII bearing B cells generate IgE-binding factors of different molecular weights. Mol. Immunol. 1989; 26: 1105
   PubMed Web of Science ®Google Scholar
• Monestier M., Bellon B., Manheimer A. J., Bona C. A. Rheumatoid factors. Immunochemical, molecular and regulatory properties. Ann. N. Y. Acad. Sci. 1986; 475: 106
   PubMed Web of Science ®Google Scholar
• Grabar P. Autoantibodies and physiological role of immunoglobulins. Immunol. Today 1983; 14: 337
   Google Scholar
• Manheimer A., Bona C. Age-dependent isotype variation during secondary immune response in MRL-1pr mice producing auto-anti-γ-globulin. J. Exp. Med. 1985; 103: 105
   Google Scholar
• St. Sinclair N. R. C., Panoskaltsis A. Rheumatoid factor and Fc signaling: a tale of two Cinderellas. Clin. Immunol. Immunopathol. 1989; 52: 133
   PubMedGoogle Scholar
• Rajnavölgyi E., Kurucz I., Fazakas G Y., Sintar E., Laszlo G., Gergely J. In vivo manipulation of IgG2a production by isotype specific autoantibodies. Mol. Immunol. 1990; 27: 1241
   PubMed Web of Science ®Google Scholar